Green Digital Diabetes Waste Project
1 other identifier
observational
49
1 country
2
Brief Summary
The purpose of this study is to determine how people with diabetes are disposing of various products and devices and at what rates so that better devices with less waste can be designed in the future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2023
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 19, 2023
CompletedFirst Submitted
Initial submission to the registry
October 3, 2023
CompletedFirst Posted
Study publicly available on registry
October 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 18, 2024
CompletedApril 24, 2024
April 1, 2024
7 months
October 3, 2023
April 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Types and Amount of Diabetes Waste
Types and Amount of Environmental Waste Related to Diabetes Management as Measured Quantitately by Survey and Qualitatively by Photos
30 days
Study Arms (2)
AID Group
We anticipate enrolling between 30 and 50 participants who will be recruited to participate in the Automated Insulin Delivery (AID) system study.
MDI + CGM Group
We anticipate that between 10 and 30 participants will be enrolled in the study and will be utilizing Multiple Daily Injections (MDI) therapy in conjunction with Continuous Glucose Monitoring (CGM). MDI therapy will be defined as administering three or more injections per day.
Eligibility Criteria
Adults with diagnosed diabetes mellitus (either Type 1 or Type 2) at least 6 months earlier, and treated with insulin and a continuous glucose monitor (CGM).
You may qualify if:
- Person with diabetes (self-identified), either type 1 or type 2, who has been diagnosed at least 6 months earlier
- Age 18 years and above
- Use of a CGM
- Use of an insulin pump or on MDI
- Access to the Internet and e-mail
- Access to a smartphone with photographic capability
- Able and willing to provide informed consent
You may not qualify if:
- Any condition which, in the opinion of an investigator, would make the subject not qualified to participate in the study.
- Adults unable to consent
- Adults unable to speak English
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
- Cognitively impaired adults
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Florida State Universitylead
- Diabetes Technology Societycollaborator
Study Sites (2)
Diabetes Technology Society
Burlingame, California, 94010, United States
Florida State University
Tallahassee, Florida, 32306, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jing Wang, PhD
Dean & Prof. of FSU College of Nursing
- PRINCIPAL INVESTIGATOR
David C Klonoff, MD
President of Diabetes Technology Society and Clinical Professor of UCSF Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 3, 2023
First Posted
October 6, 2023
Study Start
September 19, 2023
Primary Completion
April 18, 2024
Study Completion
April 18, 2024
Last Updated
April 24, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
No plan to make individual participant data (IPD) available to other researchers